199 related articles for article (PubMed ID: 18817843)
1. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media.
Neuhaus W; Wirth M; Plattner VE; Germann B; Gabor F; Noe CR
Neurosci Lett; 2008 Dec; 446(2-3):59-64. PubMed ID: 18817843
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
3. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells.
Ohtsuki S; Sato S; Yamaguchi H; Kamoi M; Asashima T; Terasaki T
J Cell Physiol; 2007 Jan; 210(1):81-6. PubMed ID: 16998798
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned media.
Neuhaus W; Germann B; Plattner VE; Gabor F; Wirth M; Noe CR
Brain Res; 2009 Jul; 1279():82-9. PubMed ID: 19445905
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the presence of blood-brain barrier tight junctions and expression of zonula occludens protein ZO-1 in vitro: a freeze-fracture and immunofluorescence study.
Gao P; Shivers RR
J Submicrosc Cytol Pathol; 2004 Jan; 36(1):7-15. PubMed ID: 15311669
[TBL] [Abstract][Full Text] [Related]
7. Specific AHNAK expression in brain endothelial cells with barrier properties.
Gentil BJ; Benaud C; Delphin C; Remy C; Berezowski V; Cecchelli R; Feraud O; Vittet D; Baudier J
J Cell Physiol; 2005 May; 203(2):362-71. PubMed ID: 15493012
[TBL] [Abstract][Full Text] [Related]
8. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
Nag S; Venugopalan R; Stewart DJ
Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
[TBL] [Abstract][Full Text] [Related]
9. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
10. Glial induction of blood-brain barrier-like L-system amino acid transport in the ECV304 cell line.
Chishty M; Reichel A; Begley DJ; Abbott NJ
Glia; 2002 Aug; 39(2):99-104. PubMed ID: 12112361
[TBL] [Abstract][Full Text] [Related]
11. Barrier functionality and transport machineries of human ECV304 cells.
Barar J; Gumbleton M; Asadi M; Omidi Y
Med Sci Monit; 2010 Jan; 16(1):BR52-60. PubMed ID: 20037486
[TBL] [Abstract][Full Text] [Related]
12. Claudin-5 expression in in vitro models of the blood-brain barrier.
Cooper I; Cohen-Kashi-Malina K; Teichberg VI
Methods Mol Biol; 2011; 762():347-54. PubMed ID: 21717369
[TBL] [Abstract][Full Text] [Related]
13. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction.
Calabria AR; Weidenfeller C; Jones AR; de Vries HE; Shusta EV
J Neurochem; 2006 May; 97(4):922-33. PubMed ID: 16573646
[TBL] [Abstract][Full Text] [Related]
14. Limited contribution of claudin-5-dependent tight junction strands to endothelial barrier function.
Fontijn RD; Rohlena J; van Marle J; Pannekoek H; Horrevoets AJ
Eur J Cell Biol; 2006 Nov; 85(11):1131-44. PubMed ID: 16959372
[TBL] [Abstract][Full Text] [Related]
15. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP.
Soma T; Chiba H; Kato-Mori Y; Wada T; Yamashita T; Kojima T; Sawada N
Exp Cell Res; 2004 Oct; 300(1):202-12. PubMed ID: 15383327
[TBL] [Abstract][Full Text] [Related]
16. Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: cellular responses to neurotoxicants malathion and lead acetate.
Balbuena P; Li W; Ehrich M
Neurotoxicology; 2011 Jan; 32(1):58-67. PubMed ID: 20970449
[TBL] [Abstract][Full Text] [Related]
17. Control of the blood-brain barrier by glucocorticoids and the cells of the neurovascular unit.
Kröll S; El-Gindi J; Thanabalasundaram G; Panpumthong P; Schrot S; Hartmann C; Galla HJ
Ann N Y Acad Sci; 2009 May; 1165():228-39. PubMed ID: 19538311
[TBL] [Abstract][Full Text] [Related]
18. Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study.
Zhang Z; McGoron AJ; Crumpler ET; Li CZ
Appl Biochem Biotechnol; 2011 Jan; 163(2):278-95. PubMed ID: 20652765
[TBL] [Abstract][Full Text] [Related]
19. Studying the neurovascular unit: an improved blood-brain barrier model.
Zehendner CM; Luhmann HJ; Kuhlmann CR
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1879-84. PubMed ID: 19638997
[TBL] [Abstract][Full Text] [Related]
20. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors.
Shimizu F; Sano Y; Abe MA; Maeda T; Ohtsuki S; Terasaki T; Kanda T
J Cell Physiol; 2011 Jan; 226(1):255-66. PubMed ID: 20665675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
